We use cookies for a better user experience. Read our Privacy Policy

I Agree

Cardiac Prosthetic Devices Market

Cardiac Prosthetic Devices Market (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves, Implantable Pacemaker and External Pacemaker) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Cardiac prosthetics are chronic alternatives that replace a damaged or diseased part in the body.Cardiac prosthetic devices are used in the treatment of blockages in heart valves. Implantation of cardiac prosthetic devices is being increasingly accepted as one of the common procedures due to a rise in the number of patients suffering from valvular diseases. Prosthetic valve thrombosis (PVT), prosthetic valve endocarditis (PVE), mechanical hemolytic anemia and thromboembolism are some of the complications that involve the failure of primary valves.

Furthermore, these devices tend to improve the quality of life by reducing the morbidity and mortality rate by replacing diseased valves. It is been estimated that more than 60,000 patients undergo heart valve replacement in the U.S. every year. Thus, the usage and acceptance of cardiac prosthetic devices is on risemainly due to technological advances and better performance. Escalation in cardiac disorder prevalence is contributed by the factors such as rise in geriatric population, high obesity epidemic and rapidly changing lifestyle. The global cardiac prosthetic devices market was valued at USD 2,945.3 million in the year 2012 and is expected to record a growth rate of 8.7% during the forecast period from 2013 to 2019, to reach an estimated value of USD 5,290.0 million by 2019.

global-cardiac-prosthetic-devices-market-by-segments-2012

The cardiac prosthetic devices market can be analyzed by the types of heart valves and pacemakers. The various types of heart valves currently available are mechanical heart valves, tissue heart valves and transcatheter heart valves. These devices are used to replace the affectedheart valves in patients. Heart valve disorders can arise from three types of malfunction: regurgitation, stenosis and atresia. A heart valve disease, if not treated in time, can lead to various heart diseases such as stroke, heart failure, cardiac arrest and blood clots. Rising geriatric population, changing lifestyle and increasing partnership among vendors are the factors influencing the growth of the heart valves market globally. Pacemakers are further categorized as implantable pacemaker and external pacemaker. Pacemakers are cardiac prosthetic devices that assist in controlling abnormal heart rhythms. These devices are implanted in patients suffering from cardiac arrhythmia, a heart disorder featured by an uneven pattern of heartbeats.

Geographically, North America accounts for the largest percentage share of the global cardiac prosthetic devices market accounting for over35% of the total market. This is justified by the presence of technologically updated infrastructure and well trained healthcare professionalsin this region compared to other regions. In addition, rising prevalence of cardiac diseases and established healthcare policies has further augmented the growth and development of cardiac prosthetic devices market in this region.Asia-Pacific region is anticipated to record high growth rate owing to increased participation of respective governments in improving the overall healthcare sector and huge untapped potential in these regions. In addition, rise in disposable incomes and increased preference of the population to avail technologically advanced medical solutions further support the growth of cardiac prosthetic devices market. 

The overall cardiac prosthetic devices market is highly fragmented with the presence of both established and emerging companies in this field that includes Edwards Lifesciences Corporation, Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Sorin Group and others. The factors that contribute in the growth of overall cardiac prosthetic devices are continuous product modifications and upgradations followed by technological advances and increased preference for minimally invasive procedures. However, high cost of the products and procedures may limit the growth prospects for the development of cardiac prosthetic devices market.

Cardiac Prosthetic Devices Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
               1.3.1.1 Secondary Research
               1.3.1.2 Primary Research

Chapter 2 Executive Summary
2.1 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
      3.2.1 Rising Geriatric Population
      3.2.2 Rising Prevalence of Disorders such as Hypertension, Diabetes and Obesity
      3.2.3 Increasing Demand for Minimally-Invasive Procedures
3.3 Market Restraints
      3.3.1 Implementation of Affordable Healthcare Act
      3.3.2 Strict Approval Process from Government Bodies
3.4 Market Opportunities
      3.4.1 Big Opportunities in Emerging Economies with High Unmet Needs
      3.4.2 Huge Scope for Alliance with Organizations having Complementary Strength
3.5 Porter’s Five Forces Analysis for the Global Cardiac Prosthetic Devices Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis for the Global Cardiac Prosthetic Devices Market, by Geography
3.7 Market Share by Key Players of Global Cardiac Prosthetic Devices Market, 2012
      3.7.1 Global Cardiac Prosthetic Devices Market Share, by Key Players, 2012 (%)
 
Chapter 4 Cardiac Prosthetic Devices Market, by Segments
4.1 Overview
      4.1.1 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
4.2 Heart Valves
      4.2.1 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
      4.2.2 Mechanical Heart Valves
               4.2.2.1 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
      4.2.3 Tissue Heart Valves
               4.2.3.1 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
               4.2.3.2 Stented Tissue Valve
                          4.2.3.2.1 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
               4.2.3.1 Stentless Tissue Valve
                          4.2.3.1.1 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
      4.2.4 Transcatheter Heart Valves
               4.2.4.1 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
4.3 Pacemaker
      4.3.1 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
      4.3.2 Implantable Pacemaker
      4.3.3 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
              4.3.3.1 Single-Chamber Battery Pacemaker
                         4.3.3.1.1 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
              4.3.3.2 Dual-Chamber Battery Pacemaker
                         4.3.3.2.1 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
              4.3.3.3 Triple-Chamber Battery Pacemaker
                         4.3.3.3.1 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
      4.3.4 External Pacemaker
              4.3.4.1 Global External Pacemaker Market, 2011 – 2019 (USD Million)
 
Chapter 5 Cardiac Prosthetic Devices Market, by Geography
5.1 Overview
      5.1.1 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.2 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
5.3 North America
      5.3.1 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.4 Europe
      5.4.1 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.5 Asia-Pacific
      5.5.1 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.6 Rest of the World (RoW)
      5.6.1 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
 
Chapter 6 Recommendations
6.1 Market Strategies for Success
6.2 Barriers to be Considered
 
Chapter 7 Company Profiles
7.1 Abbott Laboratories
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
      7.1.5 Recent Developments
7.2 Abiomed, Inc.
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategies
      7.2.5 Recent Developments
7.3 AtriCure, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
      7.3.5 Recent Developments
7.4 Boston Scientific Corporation
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
      7.4.5 Recent Developments
7.5 Edward Lifesciences Corporation
      7.5.1 Company overview
      7.5.2 Financial overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
      7.5.5 Recent Developments
7.6 Medtronic, Inc.
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
      7.6.5 Recent Developments
7.7 Siemens Healthcare
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
      7.7.5 Recent Developments
7.8 Sorin Group
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Product Portfolio
      7.8.4 Business Strategies
      7.8.5 Recent Developments
7.9 St. Jude Medical, Inc.
      7.9.1 Company Overview
      7.9.2 Financial Overview
      7.9.3 Product Portfolio
      7.9.4 Business Strategies
      7.9.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global Cardiac Prosthetic Devices Market (2012 & 2019)
TABLE 2 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
TABLE 3 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 4 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 7 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 8 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 9 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 11 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

List of Figures

 

FIG. 1 Cardiac Prosthetic Devices: Market Segmentation

FIG. 2 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)

FIG. 3 Porter’s Five Forces Analysis: Cardiac Prosthetic Devices Market

FIG. 4 Market Attractiveness Analysis: Global Cardiac Prosthetic Devices Market, by Geography

FIG. 5 Cardiac Prosthetic Devices: Market Share, by Key Players, 2012 (%)

FIG. 6 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)

FIG. 7 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)

FIG. 8 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)

FIG. 9 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)

FIG. 10 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)

FIG. 11 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)

FIG. 12 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)

FIG. 13 Global External Pacemaker Market, 2011 – 2019 (USD Million)

FIG. 14 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)

FIG. 15 Abbott Laboratories, Annual Revenue: 2010 – 2012 (USD Billion)

FIG. 16 Abiomed, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 17 AtriCure, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 18 Boston Scientific Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 19 Edward Lifesciences Corporation, Net Sales: 2010 – 2012 (USD Billion)

FIG. 20 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 21 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 22 Sorin Group, Net Sales: 2010 – 2012 (USD Million)

FIG. 23 St. Jude Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

471

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved